Novartis India Limited Financial Ratios
NOVARTIND · Healthcare · Current price ₹1,880.8
P/E ratio
49.8x
P/B ratio
7.3x
ROE
11.4%
ROCE
16.0%
Debt / Equity
0.00
Dividend yield
1.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 49.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 7.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 11.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 16.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.00 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Novartis India Limited's latest numbers.
Novartis India Limited profitability
Novartis India Limited generates a return on equity of 11.4% and a return on capital employed of 16.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.00 and a P/E of 49.8x, Novartis India Limited is conservatively financed. Our overall business-quality score for the company is 4.1 / 10.
Understand the ratios
More on Novartis India Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.